Wolverine Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wolverine Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Buy	4,700 +4,000	+571%	+$876K	0.01%	767
2026 Q1	$132K	Sell	700 -2,500	-78%	-$437K	﹤0.01%	1146
2025 Q4	$544K	Sell	3,200 -3,000	-48%	-$460K	﹤0.01%	909
2025 Q3	$817K	Buy	6,200 +2,000	+48%	+$240K	0.01%	778
2025 Q2	$446K	Buy	4,200 +2,700	+180%	+$293K	﹤0.01%	897
2025 Q1	$186K	Sell	1,500 -9,600	-86%	-$1.25M	﹤0.01%	1020
2024 Q4	$1.37M	Sell	11,100 -22,900	-67%	-$2.7M	0.01%	612
2024 Q3	$3.79M	Hold	34,000	–	–	0.04%	353
2024 Q2	$3.63M	Hold	34,000	–	–	0.04%	355
2024 Q1	$4.09M	Hold	34,000	–	–	0.05%	324
2023 Q4	$4.18M	Sell	34,000 -10,400	-23%	-$1.3M	0.04%	377
2023 Q3	$5.75M	Buy	44,400 +900	+2%	+$120K	0.06%	287
2023 Q2	$5.39M	Buy	43,500 +33,100	+318%	+$4.45M	0.06%	279
2023 Q1	$1.52M	Buy	10,400 +6,100	+142%	+$902K	0.02%	586
2022 Q4	$685K	Buy	+4,300	New	+$630K	0.01%	859

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Wolverine Asset Management's JAZZ Position: Q2 2026 in Review

Wolverine Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 76% in Q2 2026, buying an estimated $221K and bringing the position to 2,330 shares worth $561K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Wolverine Asset Management first reported a position in JAZZ in Q1 2020 and has held it in 13 quarters since. The position peaked at $1.69M in Q2 2024. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Wolverine Asset Management held 2,330 shares of Jazz Pharmaceuticals worth $561K as of Q2 2026.
Wolverine Asset Management bought 1,008 Jazz Pharmaceuticals shares in Q2 2026, an estimated $221K.
Jazz Pharmaceuticals made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #922 holding.
Wolverine Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 13 quarters since.
Wolverine Asset Management's Jazz Pharmaceuticals position peaked at $1.69M in Q2 2024.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.